Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market

Positive

AI Analysis

Summary

Tonix Pharmaceuticals received Nasdaq approval to uplist from the Nasdaq Capital Market to the Nasdaq Global Select Market, with trading expected to commence on March 3, 2026 under ticker symbol TNXP.

Outcome Details

Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market

Importance:4/10

Sentiment:

0.60

uplistingnasdaqcorporate action

Related Companies

$TNXP

Read the original article

Published by GlobeNewswire Pharma on March 3, 2026 11:00 AM

Read Original